Event: Opportunities in Innovative Health Financing with the Global Fund

Alyssa GovindanNews, Newsletter

The Global Fund Private Sector Delegation (PSD) will host an event on the sidelines of the 38th Global Fund Board meeting to discuss opportunities in innovative health financing. A significant increase in resources and funding is essential if we are to reach sustainable development goal (SDG) targets including eliminating HIV, TB and Malaria by 2030. Pressures on donor financing combined … Read More

Alyssa GovindanEvent: Opportunities in Innovative Health Financing with the Global Fund

Looking Back on the 1st Year of the GFATM New Funding Model

Nisa PatelNews, Newsletter

In May 2014, countries submitted concept notes in the first review window of the new approach to grant-making approved by the Board for full implementation just two months earlier. By the end of the year, the Technical Review Panel (TRP) had reviewed 111 concept notes, approximately 43% of all expected country submissions for the 2014-2016 allocation period and representing nearly … Read More

Nisa PatelLooking Back on the 1st Year of the GFATM New Funding Model

New Private Sector Opportunities Approved, Governance Reforms Launched at Global Fund 32nd Board Meeting

Nisa PatelArticle, Newsletter

November 18 – 21, 2014 | Montreux, Switzerland The Global Fund Board met for its 32nd Board meeting in Montreux, Switzerland from November 18-21.  Over the course of the meetings, the Board approved major decisions including: amendments allowing the private sector to make restricted financial contributions against unfunded portions of approved country grant requests reforms to enhance Board and committee … Read More

Nisa PatelNew Private Sector Opportunities Approved, Governance Reforms Launched at Global Fund 32nd Board Meeting

Recent Events and GF Results Highlight Global Progress Against the Three Diseases

Nisa PatelNews, Newsletter

On World AIDS Day, the Global Fund announced key programmatic results from Global Fund-supported grant programs in 2014, showing steady gains across indicators, including a 20% scale-up in people on anti-retroviral therapy, a 24% scale-up in bed net distribution, and a 39% scale up in people treated for multi-drug-resistant TB since 2013. Although the results indicate positive signs of progress, … Read More

Nisa PatelRecent Events and GF Results Highlight Global Progress Against the Three Diseases

Meet the PSD: Luisa Engel and Dr. Gerhard Hesse

Nisa PatelNews, Newsletter

Luisa Engel Director of External Relations, (RED) Dr. Gerhard Hesse Head of Global Partnering / Vector Control, Bayer How did (RED) become involved with the Global Fund? The Global Fund is part of (RED)’s DNA. The Fund was established in 2002 but it was struggling to get funding from the corporate sector and because its charter is to be a public-private partnership, it was … Read More

Nisa PatelMeet the PSD: Luisa Engel and Dr. Gerhard Hesse